If you have any question, please feel free to email us. We will touch with you as soon as possible.
Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) that acts as a partial agonist at 5-HT1A and dopamine D2 receptors, and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors. It received manufacturing and marketing approval in Japan for the indication of schizophrenia in 2018. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Drug Generic Name | 布瑞哌唑口崩片 |
|---|---|
| Trade Name | Brexpiprazole Orally Disintegrating Tablets |
| Brand Name | Rexulti®OD Tablets |
| Dosage Form | Tablets |
| Strength | 1mg |
| Holder | Otsuka Pharmaceutical Co., Ltd. |
| Remarks | Japan listing |
| Product Type | Reference Listed Drugs (RLDs) |
Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) that acts as a partial agonist at 5-HT1A and dopamine D2 receptors, and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors. It received manufacturing and marketing approval in Japan for the indication of schizophrenia in 2018.
Looking for more information and services? Get in touch with us today!
Email: tosun-global@upharm.cn
Wechat/WhatsApp: (+86)189-2212-0575
Hot Tags: Brexpiprazole Orally Disintegrating Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bimatoprost Ophthalmic, Phenytoin Sodium Tablets, Olanzapine Tablets, Reference Listed Drugs, Alfacalcidol Soft Capsules, Acarbose Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
